Anti-Obesity Drugs Market, 2016 - 2022 1 Click to read
  • Comments

Anti-Obesity Drugs Market, 2016 - 2022

1

Published on in “Science, Science”, language — English. 4 pages.
Global anti-obesity drugs market segmented by approved drugs: buproprion and naltrexone (Contrave), orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), and liraglutide (Saxenda). More
Subscribe for FREE